Home / PDA Letters (Cards)

PDA Letters (Cards)

Welcome New RAQAB Members

Denyse Baker, Eli Lilly and Company

The European Ban on PFASs

Taras Tim Bredel, Injecto

Testing of the Future

Heike Merget-Millitzer, PhD, Janssen Inc.

Microbiologists and Training: A Crucial Quality Connection

Donald C. Singer, Ecolab, and Radha Tirumalai, PhD, Merck & Co., Inc.

In-Situ Verification of Disinfectant Rotation for Contamination Control

Laura Brennan, Ecolab

Time to Start Using Polypropylene Vials in the Industry

Ajay Pazhayattil, PhD, cGMP World, Prasanna Sagar, PhD, Itaan Pharma, and Praveen Joseph, IPS-Integrated Project Services

The Difficult Task of Solving Contamination Puzzles

Paula Peacos and Kim Sobien, ValSource, Inc.

Artificial Intelligence and Machine Learning in the Early Stage of a Product Life Cycle

By Maria Batalha, Rui Almeida, Ângela Martinho and Daniel Pais, PhD, Valgenesis

Seven Key Takeaways from PDA’s Good Aseptic Manufacturing Conference

Patrick Nieuwenhuizen, PharmaLex

Per- and Polyfluoroalkyl Substances Ban Starting 2027

Ana Kuschel, PhD, West Pharmaceutical Services

Quality Culture Post-Pandemic

Tamer Helmy, PhD

On The Issue: Digitalization of C.C.

PDA, Inc.

2022 PDA Honor Awards: Honorary Membership

PDA, Inc.

Macro Impacts from the Micro-Universe

Kurt Jaecques, GSK, and Vineeta A. Pradhan, U.S. FDA

The 2023 PDA BioManufacturing Conference Lands in Seville, Spain

Cristiana Campa, PhD, GSK, and Elisabeth Vachette, Sartorius Stedim Biotech

2022 PDA Honor Awards: James Agalloco, Gordon Personeus, and Frederick Carleton Awards

PDA, Inc.

In-process Microbial Control During Aseptic Processing – Medium Risk

David Jaworski, PDA, Inc.

Respond to Survey on ECHA Proposed PFAS Restrictions by Aug. 4

PDA, Inc.

Maintaining Compliance with Deviation Reports: A Glimpse into the 2023 PDA Mastering Deviations Workshop

Kate Malachowski, Novavax

2022 PDA Honor Awards: PDA President’s Award

PDA, Inc.